النظام الغذائي واضطراب نقص الانتباه مع فرط النشاط
مراجع

1 2 3 4 5 6  Shum، Cheuk-wai. Systematic review on attention deficit hyperactivity disorder (ADHD) and food additives in children (Thesis). The University of Hong Kong Libraries. مؤرشف من الأصل في 2019-12-12. {{استشهاد بأطروحة}}: |archive-date= / |archive-url= timestamp mismatch (مساعدة)
↑  "Scientific Opinion on the appropriateness of the food azo-colours Tartrazine (E 102), Sunset Yellow FCF (E 110), Carmoisine (E 122), Amaranth (E 123), Ponceau 4R (E 124), Allura Red AC (E 129), Brilliant Black BN (E 151), Brown FK (E 154), Brown HT (E 155". EFSA Journal. ج. 8 ع. 10: 1778. 2010-10. DOI:10.2903/j.efsa.2010.1778. ISSN:1831-4732. مؤرشف من الأصل في 2019-12-12. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (مساعدة)
↑  Boskou, D.; Charrondiere, R.; Dusemund, B.; Gott, D.; Hallas-Møller, T.; Hulshof, K.F.A.M.; König, J.; Parent-Massin, D.; Rietjens, I.M.C.M.; Speijers, G.J.A.; Tobback, P.; Verguieva, T.; Woutersen, R.A. (14 November 2009). "Scientific Opinion on the re-evaluation of Sunset Yellow FCF (E 110) as a food additive". EFSA Journal. 7 (11): 1330. doi:10.2903/j.efsa.2009.1330.
↑  Boskou, D.; Charrondiere, R.; Dusemund, B.; Gott, D.; Hallas-Møller, T.; Hulshof, K.F.A.M.; König, J.; Parent-Massin, D.; Rietjens, I.M.C.M.; Speijers, G.J.A.; Tobback, P.; Verguieva, T.; Woutersen, R.A. (12 November 2009). "Scientific Opinion on the re-evaluation of Ponceau 4R (E 124) as a food additive". EFSA Journal. 7 (11): 1328. doi:10.2903/j.efsa.2009.1328.
↑  Aguilar, F.; Bemrah, N; Galtier, P.; Gilbert, J.; Grilli, S.; Guertler, R.; Kass, G.E.N.; Lambré, C.; Larsen, J.C.; Leblanc, J-C.; Mortensen, A.; Pratt, I.; Stankovic, I.; Strobel, S. (12 September 2009). "Scientific Opinion on the re-evaluation of Quinoline Yellow (E 104) as a food additive". EFSA Journal. 7 (11): 1329. doi:10.2903/j.efsa.2009.1329
↑  Boskou, D.; Charrondiere, R.; Dusemund, B.; Gott, D.; Hallas-Møller, T.; Hulshof, K.F.A.M.; König, J.; Parent-Massin, D.; Rietjens, I.M.C.M.; Speijers, G.J.A.; Tobback, P.; Verguieva, T.; Woutersen, R.A. (12 November 2009). "Scientific Opinion on the re-evaluation Tartrazine (E 102)". EFSA Journal. 7 (11): 1331. doi:10.2903/j.efsa.2009.1331. The Panel concludes that the present dataset does not give reason to revise the ADI of 7.5 mg/kg bw/day
↑  Encyclopedia of food safety (ط. First edition). Amsterdam. ISBN:9780123786135. OCLC:865335120. مؤرشف من الأصل في 2019-12-12. {{استشهاد بكتاب}}: |archive-date= / |archive-url= timestamp mismatch (مساعدة) و|طبعة= يحتوي على نص زائد (مساعدة)
↑  Millichap, JG; Yee, MM (February 2012). "The diet factor in attention-deficit/hyperactivity disorder". Pediatrics. 129 (2): 330–337. doi:10.1542/peds.2011-2199. PMID 22232312
↑  Benton, D (May 2008). "Sucrose and behavioral problems". Critical Reviews in Food Science and Nutrition. 48 (5): 385–401. doi:10.1080/10408390701407316. PMID 18464029
↑  Staudenmayer, Herman (1999). "Diagnoses Incorrectly Attributed to EI". Environmental Illness: Myth and Reality. Boca Raton: Lewis Publishers. pp. 58–62. ISBN 978-1-56670-305-5
↑  Hoover, D.W.; Milich, R. (August 1994). "The effects of sugar ingestion expectancies on mother-child interactions". Journal of Abnormal Child Psychology. 22 (4): 501–515. doi:10.1007/bf02168088. PMID 7963081
↑  Johnson, RJ; Gold, MS; Johnson, DR; Ishimoto, T; Lanaspa, MA; Zahniser, NR; Avena, NM (September 2011). "Attention-deficit/hyperactivity disorder: is it time to reappraise the role of sugar consumption?". Postgraduate medicine. 123 (5): 39–49. doi:10.3810/pgm.2011.09.2458. PMC 3598008 Freely accessible. PMID 21904085
↑  Young, G; Conquer, J (January 2005). "Omega-3 fatty acids and neuropsychiatric disorders". Reproduction, Nutrition, Development. 45 (1): 1–28. doi:10.1051/rnd:2005001. PMID 15865053
↑  Haag، Marianne (2003-04). "Essential Fatty Acids and the Brain". The Canadian Journal of Psychiatry. ج. 48 ع. 3: 195–203. DOI:10.1177/070674370304800308. ISSN:0706-7437. مؤرشف من الأصل في 2019-12-12. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (مساعدة)
↑  Richardson, AJ; Montgomery, P (May 2005). "The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder". Pediatrics. 115 (5): 1360–6. doi:10.1542/peds.2004-2164. PMID 15867048
↑  Huss, Michael; Volp, Andreas; Stauss-Grabo, Manuela (24 September 2010). "Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study". Lipids in Health and Disease. 9: 105. doi:10.1186/1476-511X-9-105. PMC 2955638 Freely accessible. PMID 20868469
↑  Sinn, N.; Bryan, J. (April 2007). "Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD". Journal of Developmental and Behavioral Pediatrics. 28 (2): 82–91. doi:10.1097/01.DBP.0000267558.88457.a5. PMID 17435458
↑  Frölich, J.; Döpfner, M. (March 2008). "Die Behandlung von Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen mit mehrfach ungesättigten Fettsäuren – eine wirksame Behandlungsoption?" [The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?]. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie (in German). 36 (2): 109–116. doi:10.1024/1422-4917.36.2.109. PMID 18622940
↑  Sandvik, Torbjørn (12 March 2012). Omega-3 polyunsaturated fatty acids induced gender-specific changes in activity, impulsiveness and attention in an animal model of Attention- Deficit/Hyperactivity Disorder (Master of Psychology). University of Oslo
بوابة علم النفس
بوابة طب
بوابة صحة